TRANSORAL LASER SURGERY FOR EARLY LARYNX CANCER

Abstract

Relevance. Laryngeal cancer occupies one of the leading places in the structure of malignant tumors of the head and
neck. Currently, the leading treatment method for early cancer of the vocal fold of the larynx is transoral laser surgery.
Aim. To evaluate the effectiveness of transoral laser surgery for early cancer of the vocal fold of the larynx.
Materials and method. In the period from 2015 to 2020, 18 patients with early cancer of the vocal fold of the larynx were
treated using a CO2 laser. All patients had T1 squamous cell carcinoma of the vocal fold of the larynx, of which 16 were
stage T1a and 2 were stage T1b. In accordance with the proposal of the European Laryngological Society (ELSOC),
transmuscular chordectomy (type III) and total chordectomy (type IV) were performed.
Results. The average length of patient stay in hospital was 2 days. In all cases, a satisfactory functional result was
obtained. All operated patients were monitored for at least 3 years. Local relapse was diagnosed in 2 (11.1%) patients. The
five-year survival rate was 94.4%.
Conclusions: Transoral laser surgery is an effective treatment for T1c vocal fold cancer of the larynx with satisfactory
functional results.